Assessment of anti-factor Xa activity in critically ill COVID-19 patients receiving three different anticoagulation regimens.

The major bleeding incidents were more frequent in the “below the expected anti-FXa range group” ( Table 1 ), although the difference did not reach statistical significance.

also in 111,027 other papers